(19)
(11) EP 4 146 260 A2

(12)

(88) Date of publication A3:
30.12.2021

(43) Date of publication:
15.03.2023 Bulletin 2023/11

(21) Application number: 21800236.8

(22) Date of filing: 07.05.2021
(51) International Patent Classification (IPC): 
A61K 39/00(2006.01)
A61K 45/06(2006.01)
(52) Cooperative Patent Classification (CPC):
A61K 2039/53; A61K 39/092; A61K 2039/552; A61K 39/0011; A61K 2039/876; A61K 2039/804; A61P 31/04; A61P 35/00
(86) International application number:
PCT/US2021/031204
(87) International publication number:
WO 2021/226413 (11.11.2021 Gazette 2021/45)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(30) Priority: 08.05.2020 US 202016869642

(71) Applicant: Morphogenesis, Inc.
Tampa, FL 33612 (US)

(72) Inventors:
  • LAWMAN, Michael, J., P.
    Temple Terrace, FL 33617 (US)
  • LAWMAN, Patricia, D.
    Temple Terrace, FL 33617 (US)
  • ELIZABETH, Meghan
    St. Petersburg, FL 33704 (US)
  • RAMIYA, Vijay
    Gainesville, FL 33607 (US)
  • BASTAWROUS, Marina, Victor, Abdelmaseeh
    Fort Orange, FL 32128 (US)
  • SHAMBLOTT, Michael, J.
    St. Petersburg, FL 33605 (US)

(74) Representative: Zwicker, Jörk 
ZSP Patentanwälte PartG mbB Hansastraße 32
80686 München
80686 München (DE)

   


(54) MODIFIED MRNA FOR MULTICELL TRANSFORMATION